Area of research
Cellular and Molecular Neuroscience · Epidemiology
Research interest
Research interests include Neurotransmitter Receptor Influence on Behavior, Substance Abuse Treatment and Outcomes, Alcohol Consumption and Health Effects, and Stress Responses and Cortisol.
Neuroimmune pathways as targets for precision treatment in alcohol use disorder: A commentary on biomarkers for craving
Glucagon‐like peptide‐1 receptor agonists in alcohol use disorder: Multi‐system effects, early clinical promise and uncertain long‐term use
Evaluating the age of individuals who are seeking treatment for alcohol and substance use disorder in a community-based recovery center
Intranasal insulin for the treatment of alcohol use disorder: design and methodology of an alcohol interaction randomized controlled trial
Opioid quantification via microsampling techniques to assess opioid use in human laboratory studies
Probenecid as a pharmacotherapy for alcohol use disorder: A randomized placebo‐controlled alcohol interaction trial
Mifepristone as a pharmacological intervention for stress‐induced alcohol craving: A human laboratory study
Utilizing precision medicine to treat alcohol use disorder: A commentary on the α1 receptor antagonist
Evaluating the readability of online patient-facing resources for alcohol use disorder
Mifepristone as a pharmacological intervention for stress-Induced alcohol craving: a translational crossover randomized trial
The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder
The multitarget FAAH inhibitor/D3 partial agonist ARN15381 decreases nicotine self-administration in male rats
Development and use of a high-throughput screen to identify novel modulators of the corticotropin releasing factor binding protein
Corticotropin Releasing Factor Binding Protein as a Novel Target to Restore Brain Homeostasis: Lessons Learned From Alcohol Use Disorder Research
Defining the role of corticotropin releasing factor binding protein in alcohol consumption
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity